(Health-NewsWire.Net, July 22, 2016 )
Researchmoz added Most up-to-date research on "Insulin Market in the US and Europe" to its huge collection of research reports.
About Insulin
Beta cells of the pancreas produce insulin, a hormone that regulates blood glucose levels, by stimulating cells to absorb glucose from the blood.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=717642
In the cells, glucose is converted into energy, which is used by tissues and muscles to perform their physiological functions. This process is restricted in people with diabetes, resulting in the accumulation of glucose in the blood. This condition is known as hyperglycemia; it damages body tissues over a period, leading to life-threatening health complications such as diabetic retinopathy and diabetic nephropathy. In type 1 diabetes or gestational diabetes, the immune system attacks the pancreatic cells, resulting in little or no insulin production. In type 2 diabetes, the body does not produce sufficient insulin to regulate blood glucose levels. In both type 1 and type 2 diabetes, the individual requires daily doses of insulin along with other medications, depending on the condition. Different types of insulin products, such as human insulin and insulin analogs, are available for insulin replacement therapy.
Technavios analysts forecast the insulin market in the US and Europe to grow at a CAGR of 6.17% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the insulin market in the US and Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.
Browse Detail Report With TOC @ http://www.researchmoz.us/insulin-market-in-the-us-and-europe-2016-2020-report.html
The market is divided into the following segments based on geography: US Europe
Technavio's report, Insulin Market in the US and Europe 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors Sanofi Novo Nordisk Eli Lilly Other prominent vendors Adocia Biocon Biodel Biogenomics Boehringer Ingelheim Dance Biopharm Diasome Pharmaceuticals
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=717642
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|